Moderna

95,07 EUR -1,39 (-1,44%)
Bid 95,11 EUR
Ask 95,26 EUR

Premiumpartner

Firmenbeschreibung

Moderna Inc. ist ein US amerikanisches Biotech-Unternehmen, das sich auf die Forschung und Entwicklung von Arzneimitteln auf Basis von mRNA spezialisiert. mRNA-Arzneien sind darauf ausgelegt, dass körpereigene Zellen Proteine mit therapeutischer oder vorbeugender Wirkung produzieren, die bei der Behandlung einer Vielzahl von Krankheiten helfen können. Die Anwendungsgebiete für mRNA-Produkte umfassen Therapeutika und Impfstoffe für Krebsimmuntherapien, seltene Krankheiten, Herz-Kreislauf-Erkrankungen, Autoimmunerkrankungen und Entzündungen. Die beständigen Fortschritte des Unternehmens in der Grundlagen- und angewandten mRNA-Forschung ermöglichen parallele Neuentwicklungen, sowohl unabhängig als auch mit strategischen Partnern zusammen. Es bestehen strategische Partnerschaften mit AstraZeneca PLC und Merck & Co., außerdem mit verschiedenen US-Behörden und Forschungseinrichtungen.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Baillie Gifford and Company (12.01%),Vanguard Group Inc (7.22%),Blackrock Inc. (6.35%),State Street Corporation (3.74%),Flagship Pioneering Inc. (3.39%)
sharesOutstanding: 382073208.0000
ceo: Stéphane Bancel
board: Jamey Mock, Juan Andres, Kate Cronin, Shannon Thyme Klinger, Stephen Hoge, M.D., Tracey Franklin, Dr. Jerh Collins, Arpa Garay, Brad Miller
supervisoryBoard: Dr. Noubar Afeyan, Elizabeth Nabel, M.D., Elizabeth Tallett, François Nader, M.D., Henri A. Termeer, Paul Sagan, Robert Langer, Sandra Horning, M.D., Stéphane Bancel, Stephen Berenson
countryID: 20
faceValue: 0.0001
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Biotechnologie
industryName: Biotechnologie
subsectorName: Biotechnologie
country: USA
countryName: USA

Kontakt

email: IR@modernatx.com
irWebSite: https://investors.modernatx.com/

Adresse

street: 200 Technology Square
city: Cambridge, Massachusetts 02139, USA
phone: +1-617-714-6500
fax: +1-617-583-1998
webSite: https://www.modernatx.com/
email: info@modernatx.com

Finanzen (kurz)

year: 2021 cash: 6848.0000
balanceSheetTotal: 24669.0000 liabilities: 10524.0000
totalShareholdersEquity: 14145.0000 sales: 18471.0000
investment: 18.0000 incomeBeforeTaxes: 13285.0000
netIncome: 12202.0000 cashFlow: 4224.0000
employees: 2700 currencyID: 4
units: 1000000 currency: USD
year: 2022 cash: 3205.0000
balanceSheetTotal: 25858.0000 liabilities: 6735.0000
totalShareholdersEquity: 19123.0000 sales: 19263.0000
incomeBeforeTaxes: 9575.0000 netIncome: 8362.0000
cashFlow: -3643.0000 currencyID: 4
units: 1000000 currency: USD
year: 2023 cash: 2907.0000
balanceSheetTotal: 18426.0000 liabilities: 4572.0000
shareCapital: 0.0000 totalShareholdersEquity: 13854.0000
sales: 6848.0000 incomeBeforeTaxes: -3942.0000
netIncome: -4714.0000 cashFlow: -289.0000
currencyID: 4 units: 1000000
currency: USD

Finanzen (kurz)

year: 2021
cash: 6848.0000
balanceSheetTotal: 24669.0000
liabilities: 10524.0000
totalShareholdersEquity: 14145.0000
sales: 18471.0000
investment: 18.0000
incomeBeforeTaxes: 13285.0000
netIncome: 12202.0000
cashFlow: 4224.0000
employees: 2700
currencyID: 4
units: 1000000
currency: USD
year: 2022
cash: 3205.0000
balanceSheetTotal: 25858.0000
liabilities: 6735.0000
totalShareholdersEquity: 19123.0000
sales: 19263.0000
incomeBeforeTaxes: 9575.0000
netIncome: 8362.0000
cashFlow: -3643.0000
currencyID: 4
units: 1000000
currency: USD
year: 2023
cash: 2907.0000
balanceSheetTotal: 18426.0000
liabilities: 4572.0000
shareCapital: 0.0000
totalShareholdersEquity: 13854.0000
sales: 6848.0000
incomeBeforeTaxes: -3942.0000
netIncome: -4714.0000
cashFlow: -289.0000
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2022 units: 1000000
balanceSheetTotal: 25858.0000 cash: 3205.0000
currentAssets: 13431.0000 fixedAssets: 12427.0000
liabilities: 4923.0000 totalLiabilitiesEquity: 25858.0000
totalShareholdersEquity: 19123.0000 property: 2018.0000
longTermInvestments: 8318.0000 inventories: 949.0000
accountsReceivable: 1385.0000 accountsPayable: 487.0000
liabilitiesTotal: 6735.0000 longTermDebt: 912.0000
sales: 19263.0000 netIncome: 8362.0000
operatingResult: 9420.0000 incomeInterest: 200.0000
investments: 3295.0000 incomeTaxes: 1213.0000
costGoodsSold: 5416.0000 grossProfit: 13847.0000
cashFlow: 4981.0000 cashFlowInvesting: -5176.0000
cashFlowFinancing: -3448.0000 cashFlowTotal: -3643.0000
accountingStandard: US GAAP equityRatio: 73.9539
debtEquityRatio: 35.2194 liquidityI: 65.1026
liquidityII: 93.2358 netMargin: 43.4096
grossMargin: 71.8839 cashFlowMargin: 25.8579
ebitMargin: 48.9020 ebitdaMargin: 0.0000
preTaxROE: 50.0706 preTaxROA: 37.0292
roe: 43.7274 roa: 32.3382
netIncomeGrowth: -31.4703 revenuesGrowth: 4.2878
taxExpenseRate: 12.6684 equityTurnover: 1.0073
epsBasic: 21.2600 epsDiluted: 20.1200
epsBasicGrowth: -29.8581 incomeBeforeTaxes: 9575.0000
priceEarningsRatioCompany: 8.4487 priceCashFlowRatio: 13.9318
bookValuePerShare: 49.4979 marketCap: 69394317874.2800
earningsYield: 11.8361 pegRatio: -0.2830
cashFlowPerShare: 12.8928 priceBookValueRatio: 3.6288
priceEarningsRatio: 8.2988 netEarningsPerShare: 21.6442
currency: USD
year: 2023 units: 1000000
balanceSheetTotal: 18426.0000 cash: 2907.0000
currentAssets: 10325.0000 fixedAssets: 8101.0000
liabilities: 3015.0000 totalLiabilitiesEquity: 18426.0000
totalShareholdersEquity: 13854.0000 property: 1945.0000
longTermInvestments: 4677.0000 inventories: 202.0000
accountsReceivable: 892.0000 accountsPayable: 520.0000
liabilitiesTotal: 4572.0000 longTermDebt: 575.0000
commonStock: 0.0000 preferredStock: 0.0000
sales: 6848.0000 netIncome: -4714.0000
operatingResult: -4239.0000 incomeInterest: 421.0000
investments: 4845.0000 incomeTaxes: 772.0000
costGoodsSold: 4693.0000 grossProfit: 2155.0000
cashFlow: -3118.0000 cashFlowInvesting: 4206.0000
cashFlowFinancing: -1377.0000 cashFlowTotal: -289.0000
accountingStandard: US GAAP equityRatio: 75.1872
debtEquityRatio: 33.0013 liquidityI: 96.4179
liquidityII: 126.0033 netMargin: -68.8376
grossMargin: 31.4690 cashFlowMargin: -45.5315
ebitMargin: -61.9013 ebitdaMargin: 0.0000
preTaxROE: -28.4539 preTaxROA: -21.3937
roe: -34.0263 roa: -25.5834
netIncomeGrowth: -156.3741 revenuesGrowth: -64.4500
taxExpenseRate: -19.5840 equityTurnover: 0.4943
epsBasic: -12.3300 epsDiluted: -12.3300
epsBasicGrowth: -157.9962 shareCapital: 0.0000
incomeBeforeTaxes: -3942.0000 priceCashFlowRatio: -12.1864
bookValuePerShare: 36.2601 marketCap: 37997180535.6000
earningsYield: -12.3982 cashFlowPerShare: -8.1607
priceBookValueRatio: 2.7427 netEarningsPerShare: -12.3379
currency: USD
year: 2024 priceCashFlowRatio: -12.4266
bookValuePerShare: 36.2601 marketCap: 38746044023.2800
earningsYield: -12.1586 pegRatio: 0.0521
cashFlowPerShare: -8.1607 netAssetsPerShare: 36.2601
priceBookValueRatio: 2.7967 netEarningsPerShare: -12.3379
currency: USD

Finanzen (ausführlich)

year: 2022
units: 1000000
balanceSheetTotal: 25858.0000
cash: 3205.0000
currentAssets: 13431.0000
fixedAssets: 12427.0000
liabilities: 4923.0000
totalLiabilitiesEquity: 25858.0000
totalShareholdersEquity: 19123.0000
property: 2018.0000
longTermInvestments: 8318.0000
inventories: 949.0000
accountsReceivable: 1385.0000
accountsPayable: 487.0000
liabilitiesTotal: 6735.0000
longTermDebt: 912.0000
sales: 19263.0000
netIncome: 8362.0000
operatingResult: 9420.0000
incomeInterest: 200.0000
investments: 3295.0000
incomeTaxes: 1213.0000
costGoodsSold: 5416.0000
grossProfit: 13847.0000
cashFlow: 4981.0000
cashFlowInvesting: -5176.0000
cashFlowFinancing: -3448.0000
cashFlowTotal: -3643.0000
accountingStandard: US GAAP
equityRatio: 73.9539
debtEquityRatio: 35.2194
liquidityI: 65.1026
liquidityII: 93.2358
netMargin: 43.4096
grossMargin: 71.8839
cashFlowMargin: 25.8579
ebitMargin: 48.9020
ebitdaMargin: 0.0000
preTaxROE: 50.0706
preTaxROA: 37.0292
roe: 43.7274
roa: 32.3382
netIncomeGrowth: -31.4703
revenuesGrowth: 4.2878
taxExpenseRate: 12.6684
equityTurnover: 1.0073
epsBasic: 21.2600
epsDiluted: 20.1200
epsBasicGrowth: -29.8581
incomeBeforeTaxes: 9575.0000
priceEarningsRatioCompany: 8.4487
priceCashFlowRatio: 13.9318
bookValuePerShare: 49.4979
marketCap: 69394317874.2800
earningsYield: 11.8361
pegRatio: -0.2830
cashFlowPerShare: 12.8928
priceBookValueRatio: 3.6288
priceEarningsRatio: 8.2988
netEarningsPerShare: 21.6442
currency: USD
year: 2023
units: 1000000
balanceSheetTotal: 18426.0000
cash: 2907.0000
currentAssets: 10325.0000
fixedAssets: 8101.0000
liabilities: 3015.0000
totalLiabilitiesEquity: 18426.0000
totalShareholdersEquity: 13854.0000
property: 1945.0000
longTermInvestments: 4677.0000
inventories: 202.0000
accountsReceivable: 892.0000
accountsPayable: 520.0000
liabilitiesTotal: 4572.0000
longTermDebt: 575.0000
commonStock: 0.0000
preferredStock: 0.0000
sales: 6848.0000
netIncome: -4714.0000
operatingResult: -4239.0000
incomeInterest: 421.0000
investments: 4845.0000
incomeTaxes: 772.0000
costGoodsSold: 4693.0000
grossProfit: 2155.0000
cashFlow: -3118.0000
cashFlowInvesting: 4206.0000
cashFlowFinancing: -1377.0000
cashFlowTotal: -289.0000
accountingStandard: US GAAP
equityRatio: 75.1872
debtEquityRatio: 33.0013
liquidityI: 96.4179
liquidityII: 126.0033
netMargin: -68.8376
grossMargin: 31.4690
cashFlowMargin: -45.5315
ebitMargin: -61.9013
ebitdaMargin: 0.0000
preTaxROE: -28.4539
preTaxROA: -21.3937
roe: -34.0263
roa: -25.5834
netIncomeGrowth: -156.3741
revenuesGrowth: -64.4500
taxExpenseRate: -19.5840
equityTurnover: 0.4943
epsBasic: -12.3300
epsDiluted: -12.3300
epsBasicGrowth: -157.9962
shareCapital: 0.0000
incomeBeforeTaxes: -3942.0000
priceCashFlowRatio: -12.1864
bookValuePerShare: 36.2601
marketCap: 37997180535.6000
earningsYield: -12.3982
cashFlowPerShare: -8.1607
priceBookValueRatio: 2.7427
netEarningsPerShare: -12.3379
currency: USD
year: 2024
priceCashFlowRatio: -12.4266
bookValuePerShare: 36.2601
marketCap: 38746044023.2800
earningsYield: -12.1586
pegRatio: 0.0521
cashFlowPerShare: -8.1607
netAssetsPerShare: 36.2601
priceBookValueRatio: 2.7967
netEarningsPerShare: -12.3379
currency: USD